Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
ANEB Stock — Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc (ANEB)
Updated October 16, 2026.
ANEB is a Stock. Total return is -100.0% over the past 5.4 years, 194.6 points behind SPY at 94.6%.
Anebulo Pharmaceuticals is a clinical-stage biotechnology company developing treatments for cannabis-related toxicity and acute cannabinoid intoxication, with its lead candidate, selonabant, currently in phase II clinical trials as a potential antidote for cannabis poisoning. As an early-stage biotech company with no approved products, it does not currently distribute dividends. This security appeals primarily to investors with high risk tolerance seeking exposure to development-stage pharmaceutical research rather than income-focused investors.
ANEB performance versus SPY
Price and return data through 2026-10-16.
Total return is -100.0% over the past 5.4 years, 194.6 points behind SPY at 94.6%. Over the past year its total return — price change plus distributions reinvested — is -100.0%. Its deepest 1-year drawdown was 100.0%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -99.9% | — |
| 3M | -99.9% | — |
| 6M | -99.9% | — |
| YTD | -100.0% | — |
| 1Y | -100.0% | — |
| 2Y CAGR | — | -98.50% |
| 3Y CAGR | — | -93.80% |
| 5Y CAGR | — | -85.90% |
| Since inception (5.4 years) | -100.0% | -83.40% |
ANEB key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 05/07/2021
- Distribution frequency
- None
- Last close
- $0.0004 (as of 2026-10-16)
- Market cap
- $16,314
- Average volume
- 750.0
- Beta
- -1.89
- Payout ratio
- 0.0%
- EPS
- $-0.19
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
ANEB risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 100.0%.
Who may consider ANEB — and who may not
It is a weaker fit for investors who need monthly cash flow (ANEB does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on ANEB
Frequently asked questions
Does ANEB pay monthly?
No. ANEB does not currently distribute.
When does ANEB pay a dividend?
ANEB does not currently distribute.
How has ANEB performed?
Total return is -100.0% over the past 5.4 years, 194.6 points behind SPY at 94.6%. Over the past year its total return — price change plus distributions reinvested — is -100.0%. Its deepest 1-year drawdown was 100.0%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.